首页> 外国专利> 3 AN AGENT FOR DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL COMPRISING vitamin D3 AND A METHOD OF DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL USING THEREOF

3 AN AGENT FOR DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL COMPRISING vitamin D3 AND A METHOD OF DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL USING THEREOF

机译:3将造血干细胞分化为包含维生素D3的天然杀伤细胞的方法,以及利用该方法将造血干细胞分化为天然杀伤细胞的方法

摘要

The present invention is to control the cell minutes agent and relates to a cell differentiation method, more specifically, VDUP1 (Vitamin D3 upregulating protein 1) protein or a gene or VDUP1 encoding him using a differentiation regulating gene into NK cells in the stem cell in minutes using the same agent, and hematopoietic stem cells containing vitamin D3 as an active ingredient it relates to a method of differentiating into NK cells. VDUP1 gene of the present invention has determined, in the stem cells in the conventional in that is not known to control the differentiation into NK cells genetically, by producing the mice deficient for the gene and differentiation regulation of a natural killer cell, the gene by controlling the differentiation into NK cells in killing tumor cells that function through the regulation it may be useful for anticancer cell therapy. ; Vitamin D3, the natural killer cells topics minutes, hematopoietic stem cells
机译:本发明涉及控制细胞分钟剂,并且涉及细胞分化方法,更具体地,涉及使用分化调节基因将VDUP1(维生素D3上调蛋白1)蛋白或编码他的基因或VDUP1编码到干细胞中的NK细胞中。在同一分钟内使用相同的试剂,并且含有维生素D3作为活性成分的造血干细胞涉及分化为NK细胞的方法。在本发明的VDUP1基因中,通过产生缺乏该基因和自然杀伤细胞的分化调控的小鼠,可以确定在传统的干细胞中尚不知道遗传上控制向NK细胞的分化。通过杀死通过调节功能起作用的肿瘤细胞来控制向NK细胞的分化,这对于抗癌细胞疗法可能是有用的。 ;维生素D3,自然杀伤细胞主题,造血干细胞

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号